Physician profile
Emily Murphy
NPI 1063894103
$2,527.42
in general payments reported to CMS, 2019-2025
20 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $602 · 2022: $539 · 2023: $621 · 2024: $446 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900 · Education: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.35 |
| Education | $486.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $534.86 | 2021-2025 | |
| Janssen Biotech, INC. | $421.45 | 2022-2025 | Tremfya, Stelara, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $328.57 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $217.06 | 2021-2024 | Dupixent, Libtayo |
| Janssen Scientific Affairs, LLC | $144.76 | 2021-2022 | |
| Incyte Corporation | $115.55 | 2023 | Opzelura |
| Galderma Laboratories, L.P. | $98.43 | 2024-2025 | Nemluvio |
| Mayne Pharma Commercial LLC | $90.12 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $85.46 | 2021-2024 | |
| Ucb, INC. | $81.69 | 2021-2025 | Bimzelx |
| Amgen INC. | $81.40 | 2021-2025 | Otezla, Enbrel, Otezla |
| Sanofi-Aventis U.S. LLC | $79.99 | 2021 | |
| Lilly USA, LLC | $63.34 | 2022 | |
| Pfizer INC. | $47.48 | 2021-2023 | |
| Arcutis Biotherapeutics, INC. | $44.54 | 2025 | Zoryve |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $25.35 | 2021-2023 | |
| Biofrontera INC. | $19.86 | 2025 | |
| Allergan, INC. | $18.86 | 2022 | |
| Leo Pharma INC. | $17.73 | 2021 | |
| Organon LLC | $10.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.